|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$7.76 |
$7.78 |
$7.44 |
$7.47 |
1.27M | 03/25/2024 |
$7.46 |
$7.59 |
$7.32 |
$7.36 |
1.17M | 03/26/2024 |
$7.46 |
$7.58 |
$7.20 |
$7.22 |
1.85M | 03/27/2024 |
$7.31 |
$7.53 |
$7.18 |
$7.44 |
1.28M | 03/28/2024 |
$7.46 |
$7.52 |
$7.37 |
$7.42 |
1.56M |
|
Editas Medicine is a clinical stage genome editing company focused on developing genomic medicines to treat a range of serious diseases. Co. has developed a proprietary genome editing platform based on clustered, regularly interspaced, short palindromic repeats technology and it continues to expand its capabilities. Co. is developing in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, ex vivo gene-edited cell medicines, in which cells collected from a patient are edited with Co.'s technology and then administered back to that same patient, and cellular therapy medicines. | |
|
Editas Medicine (EDIT) has the following price history information. Looking back at EDIT historical stock prices for the last five trading days, on March 22, 2024, EDIT opened at $7.76, traded as high as $7.78 and as low as $7.44, and closed at $7.47. Trading volume was a total of 1.27M shares. On March 25, 2024, EDIT opened at $7.46, traded as high as $7.59 and as low as $7.32, and closed at $7.36. Trading volume was a total of 1.17M shares. On March 26, 2024, EDIT opened at $7.46, traded as high as $7.58 and as low as $7.20, and closed at $7.22. Trading volume was a total of 1.85M shares. On March 27, 2024, EDIT opened at $7.31, traded as high as $7.53 and as low as $7.18, and closed at $7.44. Trading volume was a total of 1.28M shares. On March 28, 2024, EDIT opened at $7.46, traded as high as $7.52 and as low as $7.37, and closed at $7.42. Trading volume was a total of 1.56M shares.
EDIT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Editas Medicine shares, starting with a $10,000 purchase of EDIT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/05/2016 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$17.60 |
|
End price/share: |
$7.42 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-57.84% |
|
Average Annual Total Return: |
-10.06% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,216.35 |
|
Years: |
8.15 |
|
|
|
Date |
Close |
03/22/2024 | $7.47 | 03/25/2024 | $7.36 | 03/26/2024 | $7.22 | 03/27/2024 | $7.44 | 03/28/2024 | $7.42 |
|
|